Today, Explained
Hot and bothered
May 26, 2023
Jancee Dunn, a health writer for the New York Times and author of "Hot and Bothered," dives into the groundbreaking approval of a new drug for menopause-related hot flashes. She sheds light on the cultural stigma surrounding menopause and the pressing need for open conversations about women's health. Dunn discusses the emotional and physical turmoil of perimenopause and emphasizes the importance of addressing the generational shifts in perceptions. With the introduction of fun ideas like a 'menopause shower,' she advocates for normalizing these crucial discussions.
26:06
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- A new non-hormonal drug, Fezzolina tan, has been FDA-approved to reduce menopausal hot flashes effectively within four weeks.
- Societal silence and lack of open dialogue around menopause emphasize the need for normalized conversations and increased awareness.
Deep dives
Menopause Treatment Advancement
A new FDA-approved non-hormonal drug, Fezzolina tan, has been introduced to effectively reduce hot flashes associated with menopause, offering relief within four weeks. This groundbreaking advancement addresses a common yet often overlooked side effect of menopause that impacts half of the global population. The drug's efficacy has been celebrated for its significant reduction in hot flash symptoms, providing hope for individuals experiencing menopausal discomfort.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
